Localization of IL-17+Foxp3+ T Cells in Esophageal Cancer

REFERENCES

• Ayyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G., Valmori, D. (2009). Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc. Natl. Acad. Sci. U SA 106:8635–8640.
   PubMed Web of Science ®Google Scholar
• Dannull, J., Su, Z., Rizzieri, D., Yang, B. K., Coleman, D., Yancey, D., Zhang, A., Dahm, P., Chao, N., Gilboa, E., Vieweg, J. (2005). Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115:3623–3633.
   PubMed Web of Science ®Google Scholar
• de Jong, E., Suddason, T., Lord, G. M. Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells. Clin. Exp. Immunol. 2010 Feb;159(2):148–158.
   PubMedGoogle Scholar
• Falk, J., Carstens, H., Lundell, L., Albertsson, M. (2007). Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol. 46: 10701074.
   PubMedGoogle Scholar
• Hadrup, R., Schumacher, T.N. (2010). MHC-based detection of antigen-specific CD8+ T cell responses. Cancer Immunol. Immunother. 59:1425–1433.
   PubMedGoogle Scholar
• Hirahara, N., Nio, Y., Sasaki, S., Minari, Y., Takamura, M., Iguchi, C., Dong, M., Yamasawa, K., Tamura, K. (2001). Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice. Oncology 61:79–89.
   PubMed Web of Science ®Google Scholar
• Hulscher, J. B., van Sandick, J. W., de Boer, A. G., Wijnhoven, B. P., Tijssen, J. G., Fockens, P., Stalmeier, P. F., ten Kate, F.J., van Dekken, H., Obertop, H., Tilanus, H. W., van Lanschot, J. J. (2002). Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N. Engl. J. Med. 347:1662–1669.
   PubMed Web of Science ®Google Scholar
• Ji, Y., Zhang, W. (2010). Th17 cells: positive or negative role in tumor? Cancer Immunol. Immunother. 59:979–987.
   Google Scholar
• Kim, S. Y., Choi, Y. J., Joung, S. M., Lee, B. H., Jung, Y. S., Lee, J. Y. (2010). Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology 129:516–524.
   PubMed Web of Science ®Google Scholar
• Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A., Zou, W. (2007). Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178:6730–6733.
   PubMed Web of Science ®Google Scholar
• Lall, H., Coughlan, K., Sumbayev, V. V. (2008). HIF-1alpha protein is an essential factor for protection of myeloid cells against LPS-induced depletion of ATP and apoptosis that supports Toll-like receptor 4-mediated production of IL-6. Mol. Immunol. 45:3045–3049.
   PubMed Web of Science ®Google Scholar
• Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., Oft, M. (2006). IL-23 promotes tumour incidence and growth. Nature 442:461–465.
   PubMed Web of Science ®Google Scholar
• Lyakh, L., Trinchieri, G., Provezza, L., Carra, G., Gerosa, F. (2008). Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 226:112–131.
   PubMed Web of Science ®Google Scholar
• Maruyama, T., Kono, K., Izawa, S., Mizukami, Y., Kawaguchi, Y., Mimura, K., Watanabe, M., Fujii, H. (2010). CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma. Dis Esophagus 223:422–429.
   Google Scholar
• Sant, A. J., Chaves, F. A., Jenks, S. A., Richards, K. A., Menges, P., Weaver, J. M., Lazarski, C. A. (2005). The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 207:261–278.
   PubMed Web of Science ®Google Scholar
• Sutmuller, R. P., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N., Wildenberg, M. E., Allison, J. P., Toes, R. E., Offringa, R., Melief, C. J. (2001). Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194: 823–832.
   PubMed Web of Science ®Google Scholar
• Voo, K. S., Wang, Y. H., Santori, F. R., Boggiano, C., Wang, Y. H., Arima, K., Bover, L., Hanabuchi, S., Khalili, J., Marinova, E., Zheng, B., Littman, D. R., Liu, Y. J. (2009). Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 106:4793–4798.
   PubMed Web of Science ®Google Scholar
• Ye, P., Garvey, P. B., Zhang, P., Nelson, S., Bagby, G., Summer, W. R., Schwarzenberger, P., Shellito, J. E., Kolls, J. K. (2001). Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25:335–340.
   PubMed Web of Science ®Google Scholar
• Zhang, J. P., Yan, J., Xu, J., Pang, X. H., Chen, M. S., Li, L., Wu, C., Li, S. P., Zheng, L. (2009). Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 50:980–989.
   PubMed Web of Science ®Google Scholar
• Zou, W., Restifo, N. P. (2010). T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 110:248–256.
   Google Scholar